Neuromodulation has emerged as a powerful therapeutic strategy for addressing a wide range of movement disorders (MDs), significantly improving the quality of life (QoL) for affected individuals. Conditions such as Parkinson’s disease (PD), essential tremor (ET), and dystonia are characterized by debilitating motor impairments that can drastically impact independence and overall well-being. Over the past several decades, the field of neuromodulation has experienced remarkable advancements, beginning with the pioneering use of deep brain stimulation (DBS) in the 1990s and expanding to include diverse approaches such as transcranial magnetic stimulation, vagus nerve stimulation, and focused ultrasound. These technological innovations have enabled clinicians to tailor interventions more precisely, fostering personalized and sophisticated management strategies. Neuromodulation has demonstrated efficacy in treating various MDs, including PD, ET, dystonia, Tourette syndrome (TS), and Huntington’s disease (HD). Advanced techniques like DBS have been shown to significantly enhance motor function, alleviate symptom severity, and improve daily living activities. Furthermore, these therapies have had a profound positive effect on patients’ emotional and psychological well-being by lessening physical burdens and promoting greater independence and social interaction. Furthermore, neuromodulation has shown a considerable promise in treating other MDs such as TS, HD, ataxia syndromes, neuroacanthocytosis, and orthostatic tremor. The wide range of neuromodulation techniques enables personalized and customized management, thereby improving patient outcomes. Despite the significant clinical benefits demonstrated by advancements in neuromodulation, challenges and limitations remain. The technical complexity of procedures, potential side effects, and variability in patient responses are notable obstacles. Nevertheless, the future of neuromodulation is promising, with ongoing technological innovations, personalized treatment strategies, and the integration of complementary therapeutic approaches. These developments have the potential to greatly enhance the QoL for patients suffering from these debilitating disorders.